Nirmaya Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 01-07-2024
- Paid Up Capital ₹ 1.10 Cr
as on 01-07-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.10 Cr
as on 01-07-2024
- Revenue 1456685.00%
(FY 2020)
- Profit -3338979.00%
(FY 2020)
- Ebitda -85218.00%
(FY 2020)
- Net Worth -25.38%
(FY 2020)
- Total Assets 269.13%
(FY 2020)
About Nirmaya Life Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.10 Cr.
The company currently has active open charges totaling ₹8.10 Cr.
Chaitanya Gandhi, Ghanshyambhai Gandhi, and Alkaben Gandhi serve as directors at the Company.
- CIN/LLPIN
U24299GJ2018PTC102387
- Company No.
102387
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 May 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Nirmaya Life Science Private Limited offer?
Nirmaya Life Science Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Ayurvedic Tablets, Ayurvedic Herbal Syrups & Tonics, Common Disease Medicines, Hair Growth Medicine, Cosmetics, Hair & Beauty Products, Body Care Products, Hair Oil, Hand Sanitizers & Personal Hygiene.
Who are the key members and board of directors at Nirmaya Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chaitanya Gandhi  | Director | 16-May-2018 | Current |
| Ghanshyambhai Gandhi | Director | 24-Dec-2018 | Current |
| Alkaben Gandhi | Director | 24-Dec-2018 | Current |
Financial Performance and Corporate Structure Insights of Nirmaya Life Science.
Nirmaya Life Science Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1456685% increase. The company also saw a substantial fall in profitability, with a 3338979% decrease in profit. The company's net worth observed a substantial decline by a decrease of 25.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirmaya Life Science?
In 2020, Nirmaya Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nirmaya Laboratories Private Limited
Active
28 years 2 months Ghanshyambhai Gandhi and Alkaben Gandhi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Aug 2019 | ₹2.70 Cr | Open |
Others Creation Date: 07 Aug 2019 | ₹2.70 Cr | Open |
Others Creation Date: 07 Aug 2019 | ₹2.70 Cr | Open |
How Many Employees Work at Nirmaya Life Science?
Unlock and access historical data on people associated with Nirmaya Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Aug 12, 2019, Nirmaya Life Science has raised a total of ₹ 1.1 Cr, with the most recent deal valued at ₹ 1 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
